Biotech

All Articles

Sanofi pays for $110M upfront for late-stage radioligand therapy

.Sanofi has actually brought in a late entrance to the radioligand celebration, paying for 100 thous...

F 2G rears $100M for second effort to receive brand-new antifungal to market

.After F2G's initial effort to get a new training class of antifungal to market was thwarted due to ...

Moderna targets $1.1 B in R&ampD spending cuts, falls 5 plans amid profitability stress

.Moderna has actually promised to reduce R&ampD spending by $1.1 billion through 2027. The choice to...

Sanofi's $80M bet on Pivot dystrophy drug finishes in period 3 crash

.Merely four months after Sanofi wager $80 thousand in beforehand cash on Fulcrum Therapies' losmapi...

Oncternal assets sinks 60% in the middle of unemployments, trial firings

.Cancer business Oncternal Therapies is folding all its own scientific tests and also giving up team...

Roche is holding out hopes that its own injectable being overweight prospect can eventually display 25% effective weight loss in late-stage trial

.Roche is actually keeping out chances that its own injectable weight problems prospect might eventu...

Novo Nordisk hails 'exceptional' weight management lead for dual-acting dental medicine in early test

.Novo Nordisk has actually elevated the top on a stage 1 trial of its own oral amylin and also GLP-1...

AbbVie files a claim against BeiGene over blood stream cancer cells medicine trade secrets

.Simply a handful of brief full weeks after gaining an FDA Fast Track tag for its own investigationa...

Lilly provides one-two punch with second tranche of favorable records on regular blood insulin prospect

.Not long after a positive data decline for Eli Lilly's efsitora alfa, the Indianapolis-based compan...

BridgeBio cuts genetics therapy finances as professional data disappoint

.BridgeBio Pharma is slashing its own gene therapy budget plan and also drawing back from the method...